Tanya Hayden - Jun 19, 2022 Form 3 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Chief Operating Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Stock symbol
ACER
Transactions as of
Jun 19, 2022
Transactions value $
$0
Form type
3
Date filed
6/22/2022, 04:04 PM
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACER Employee Stock Option (right to buy) Jun 19, 2022 Common Stock 30K $2.96 Direct F1
holding ACER Employee Stock Option (right to buy) Jun 19, 2022 Common Stock 12.5K $2.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years. The option was granted on June 1, 2021.
F2 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years. The option was granted on January 14, 2022.

Remarks:

Exhibit List: Exhibit 24 - Confirming Statement